Outlook Therapeutics faces a pivotal FDA decision for Lytenava on December 31st, following two prior rejections. Read why ...

MDR, MDSAP, and FDA audits demand rigorous preparation, lifecycle traceability, and risk-based compliance for global market ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

Explore the potential of polysaccharide microneedles in cancer immunotherapy for effective drug delivery and immune ...

The Navy's new frigate will be obsolete from the start. It's not great, but it is what we have, and if many can be built a ...

Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.

Autonomous trucking product liability risks are rising as technology outpaces regulations. Explore legal challenges, ...

A structured data ownership model—rooted in ICH GCP principles, supported by MHRA and FDA interpretations, and documented in validated system specifications—will enable sponsors to maintain compliance ...

Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory ...

A study published earlier this year in the Journal of Neuro-Oncology indicates that sonodynamic therapy (SDT) safely destroys GBM cells while preserving healthy brain tissue. Using a noninvasive ...

ProMed, a leading contract manufacturer specializing in medical-grade silicone and plastic components, provides comprehensive support for medical device, pharmaceutical, and combination drug-device ...

Tools such as CRISPR can edit genes with precision, but the process of determining which genes to target is costly and slow, ...